Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$58.01−2.56 (-4.23%)
Close on Nov 17, 2026Market cap $2.84BP/E –Yield –
Celcuity net income
Net income is the profit left for shareholders after every expense, interest and tax.
Celcuity's net income for the twelve months ending Jun 30, 2026 was -$226.48M. For fiscal 2025 it was -$177.04M. The highest annual figure on record is -$3.31M in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$177.04M | – |
| FY2024 | Dec 31, 2024 | -$111.78M | – |
| FY2023 | Dec 31, 2023 | -$63.78M | – |
| FY2022 | Dec 31, 2022 | -$40.37M | – |
| FY2021 | Dec 31, 2021 | -$29.61M | – |
| FY2020 | Dec 31, 2020 | -$9.47M | – |
| FY2019 | Dec 31, 2019 | -$7.36M | – |
| FY2018 | Dec 31, 2018 | -$7.48M | – |
| FY2017 | Dec 31, 2017 | -$6.25M | – |
| FY2016 | Dec 31, 2016 | -$3.31M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$78.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$52.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$50.97M | – |
| Q3 FY2025 | Sep 30, 2025 | -$43.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$45.27M | – |
| Q1 FY2025 | Mar 31, 2025 | -$37.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$36.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$29.79M | – |
| Q2 FY2024 | Jun 30, 2024 | -$23.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$21.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.85M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.40M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.58M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.96M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.03M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.79M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.47M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.20M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.81M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.98M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.72M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.85M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.83M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.87M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.82M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.97M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.72M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.76M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.78M | – |
| Q1 FY2017 | Mar 31, 2017 | -$987.35K | – |
| Q4 FY2016 | Dec 31, 2016 | -$902.43K | – |
| Q3 FY2016 | Sep 30, 2016 | -$868.52K | – |
See a number that looks wrong?